Request Deal Involvement

BD completed the acquisition of the Critical Care Product Group of Edwards Lifesciences for $4.2bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Cassels Brock & Blackwell

legal advisors

Cassels Brock & Blackwell

FGS Global

pr advisors

FGS Global

Perella Weinberg Partners

financial advisors

Perella Weinberg Partners

Citigroup

financial advisors

Citigroup

Ropes & Gray

legal advisors

Ropes & Gray

Morgan Stanley

financial advisors

Morgan Stanley

Goldman Sachs

financial advisors

Goldman Sachs

Skadden Arps Slate Meagher & Flom

legal advisors

Skadden Arps Slate Meagher & Flom

FGS Global

pr advisors

FGS Global

Eversheds Sutherland

legal advisors

Eversheds Sutherland

Posse Herrera & Ruiz

legal advisors

Posse Herrera & Ruiz

or

Principals

EDWARDS LIFESCIENCES (CRITICAL-CARE UNIT)

target

EDWARDS LIFESCIENCES (CRITICAL-CARE UNIT)

BECTON DICKINSON & COMPANY

bidder

BECTON DICKINSON & COMPANY

EDWARDS LIFESCIENCES

vendor

EDWARDS LIFESCIENCES

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - BD completed the acquisition of the Critical Care Product Group of Edwards Lifesciences for $4.2bn.